PATHWARD director granted 1,650 shares of stock
PATHWARD FINANCIAL, INC. director Christopher Perretta reported an equity award of company stock.
Rhea-AI Filing Summary
PATHWARD FINANCIAL, INC. director Christopher Perretta reported an equity award of company stock. He acquired 1,650 shares of common stock on February 24, 2026 at a stated price of $0.00 per share, reflecting a grant rather than an open-market purchase. Following this award, his directly owned position increased to 8,350 common shares. The filing notes that the award was granted pursuant to the company’s 2023 Omnibus Incentive Plan, which is used to provide stock-based compensation to eligible participants.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 1,650 shares
Grant/Award
1 txn
Insider
Perretta Christopher
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,650 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 8,350 shares (Direct)
Footnotes (1)
- F1. Award pursuant to the Company's 2023 Omnibus Incentive Plan.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did PATHWARD FINANCIAL (CASH) report for Christopher Perretta?
PATHWARD FINANCIAL reported that director Christopher Perretta received an award of 1,650 shares of common stock. The shares were granted as equity compensation, not bought on the open market, under the company’s 2023 Omnibus Incentive Plan.
Was the PATHWARD FINANCIAL (CASH) insider transaction a market purchase or a stock grant?
The transaction was a stock grant, not a market purchase. Director Christopher Perretta received 1,650 common shares at a stated price of $0.00 per share, consistent with an equity award issued under the 2023 Omnibus Incentive Plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.